10 Omnicell Analyst Ratings, Earnings, Dividends and Insider Trades | $OMCL | NASDAQ:OMCL | Analyst Ratings Network Follow @RatingsNetwork Find a Company: Login Stock Ratings Today's Ratings U.S. Analyst Ratings (NYSE and NASDAQ) All U.S. Ratings Upgrades Downgrades New Coverage Price Target Changes Rating Reiterations Canadian Analyst Ratings (TSE and TSV) U.K. Analyst Ratings (LSE) Australian Analyst Ratings (ASX) Lookup Company Ratings Free Ratings Newsletter ARN Daily Premium ($) RatingsDB ($) Stock Ratings App Earnings Today's Announcements Tomorrow's Announcements Free Earnings Newsletter CER Wire Premium ($) Lookup Company Earnings Dividends Insider Trades About Contact Omnicell Company Profile (NASDAQ:OMCL) Tweet Analyst RatingsEarningsDividendsInsider TradesCompany ProfileSocial ActivityToday's Chart Consensus Ratings for Omnicell (NASDAQ:OMCL) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.Ratings Breakdown: 3 Hold Rating(s), 5 Buy Rating(s)Consensus Rating:Buy (Score: 2.63)Consensus Price Target: $28.60 1.45% downside) Analysts' Ratings History for Omnicell (NASDAQ:OMCL) Show: All Ratings For This Stock Only the Most Recent Rating From Each Brokerage DateFirmActionRatingPrice TargetDetailsShare3/5/2014LaidlawBoost Price TargetBuy$29.00 -> $34.00View 2/21/2014ZacksUpgradeUnderperform -> Neutral$29.00View 1/28/2014LaidlawBoost Price TargetBuy$27.00 -> $29.00View 12/13/2013B. RileyUpgradeNeutral -> Buy$28.00View 11/22/2013ZacksDowngradeNeutral -> Underperform$22.00View 11/1/2013Cowen and CompanyBoost Price TargetMarket Perform$21.00 -> $24.00View 11/1/2013Craig HallumDowngradeBuy -> HoldView 10/31/2013FBR & Co.UpgradeMarket Perform -> OutperformView 10/31/2013FBR Capital MarketsInitiated CoverageOutperform$28.00View 9/26/2013B. RileyDowngradeBuy -> Neutral$26.00View 8/21/2013ZacksReiterated RatingNeutral -> Neutral$24.00View 8/2/2013Cowen and CompanyBoost Price TargetMarket Perform$18.00 -> $21.00View 6/3/2013SidotiInitiated CoverageBuyView 5/22/2013ZacksReiterated RatingNeutral -> Neutral$19.00View 3/19/2013ZacksReiterated RatingNeutral -> Neutral$19.00View 2/21/2013B. RileyInitiated CoverageBuy$22.00View 2/21/2013B. RileyInitiated CoverageBuy$22.00View 2/4/2013ZacksReiterated RatingNeutral -> Neutral$19.00View 2/1/2013Benchmark Co.Boost Price Target$21.00View 1/25/2013Benchmark Co.Initiated CoverageBuy$19.00 -> $19.00View 12/28/2012ZacksReiterated RatingNeutral -> Neutral$16.00View 12/19/2012Wells Fargo & Co.Initiated CoverageMarket PerformView 10/15/2012ZacksReiterated RatingNeutral -> Neutral$14.00View 9/7/2012ThinkEquityInitiated CoverageBuy$18.00View 8/13/2012ZacksReiterated RatingNeutral -> Neutral$15.00View 6/13/2012Piper JaffrayLower Price TargetOverweight$16.00View 5/23/2012Lazard Ltd.Initiated CoverageNeutralView 5/21/2012ZacksReiterated RatingNeutral -> Neutral$15.00View 5/3/2012AurigaReiterated RatingBuyView (Data available from 3/11/2012 forward) Earnings History for Omnicell (NASDAQ:OMCL)DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare2/4/2014Q413$0.28$0.29$101.13 million$105.80 millionViewListenView 10/31/2013Q313$0.28$0.31$94.96 million$94.03 millionViewN/AView 8/1/2013Q2 2013$0.25$0.27$92.42 million$93.70 millionViewN/AView 5/2/2013Q1 2013$0.19$0.21$87.20 million$87.11 millionViewN/AView 1/31/2013Q4 2012$0.25$0.25$87.31 million$90.16 millionViewN/AView 10/25/2012$0.22$0.29ViewN/AView 8/1/2012$0.18$0.20ViewN/AView 5/2/2012$0.13$0.13ViewN/AView 1/26/2012$0.16$0.19ViewN/AView 10/27/2011$0.16$0.16ViewN/AView 7/28/2011$0.13$0.15ViewN/AView 5/2/2011$0.10$0.11ViewN/AView 1/27/2011$0.12$0.11ViewN/AView (Data available from 1/1/2011 forward) Dividend History for Omnicell (NASDAQ:OMCL)No dividend announcements for this company have been tracked by Analyst Ratings Network Insider Trading History for Omnicell (NASDAQ:OMCL)Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionSEC LinkShare12/18/2013Nhat NgoVPSell1,462$24.43$35,716.66View 12/18/2013Randall LippsCEOSell64,739$24.30$1,573,157.70View 12/3/2013Dan JohnstonVPSell73,419$23.24$1,706,257.56View 11/11/2013Randy LindholmDirectorSell3,587$23.00$82,501.00View 11/7/2013Dan JohnstonVPSell8,000$22.99$183,920.00View 10/23/2013Robin Gene SeimCFOSell7,664$24.50$187,768.00View 10/21/2013Robin Gene SeimCFOSell9,349$23.76$222,132.24View 10/1/2013James T JudsonDirectorSell5,000$23.66$118,300.00View 9/24/2013Randall LippsCEOSell68,204$25.00$1,705,100.00View 9/23/2013Marga Ortigas-WedekindVPSell4,000$25.00$100,000.00View 9/23/2013Randall LippsCEOSell5,083$25.00$127,075.00View 9/20/2013Robin Gene SeimCFOSell27,500$24.35$669,625.00View 9/18/2013Randall LippsCEOSell64,453$23.67$1,525,602.51View 9/4/2013Nhat H NgoVPSell7,362$24.00$176,688.00View 9/3/2013James JudsonDirectorSell5,000$22.77$113,850.00View 8/20/2013James JudsonDirectorSell11,724$22.74$266,603.76View 8/13/2013J Christopher DrewVPSell20,000$22.83$456,600.00View 8/12/2013Donald WegmillerDirectorSell34,976$22.87$799,901.12View 8/7/2013Dan JohnstonVPSell8,000$22.92$183,360.00View 8/6/2013Randall LippsCEOSell5,321$23.00$122,383.00View 8/2/2013Randall A LippsCEOSell25,000$22.50$562,500.00View 8/1/2013James JudsonDirectorSell5,000$21.00$105,000.00View 7/19/2013Nhat H NgoVPSell41,875$21.00$879,375.00View 7/19/2013Randall A LippsCEOSell5,080$21.00$106,680.00View 7/1/2013James T JudsonDirectorSell5,000$20.46$102,300.00View 7/1/2013Robin Gene SeimCFOSell13,032$20.42$266,113.44View 6/28/2013Marga Ortigas-WedekindVPSell4,545$20.00$90,900.00View 6/28/2013Randall A LippsCEOSell25,000$20.00$500,000.00View 6/21/2013Nhat H NgoVPSell3,459$19.01$65,755.59View 6/18/2013Randall A LippsCEOSell66,378$19.10$1,267,819.80View 6/10/2013Randy D LindholmDirectorSell23,901$19.14$457,465.14View 6/4/2013Robin Gene SeimCFOSell25,000$18.72$468,000.00View 5/22/2013Gary S PetersmeyerDirectorSell2,750$18.10$49,775.00View 5/16/2013J Christopher DrewVPSell26,000$18.69$485,940.00View 5/14/2013J Christopher DrewVPSell26,000$18.45$479,700.00View 5/10/2013Sara J WhiteDirectorSell7,200$18.50$133,200.00View 5/7/2013Dan S JohnstonVPSell8,000$18.44$147,520.00View 12/3/2012Gary S PetersmeyerDirectorSell1,359$15.17$20,616.03View (Data available from 1/1/2013 forward) About Omnicell Omnicell, Inc. (Omnicell) is a provider of automated solutions for hospital medication and supply management. The Company's automation and analytics solutions are designed to enable healthcare facilities to acquire, manage, dispense and administer medications and medical-surgical supplies. Its systems provide medication control and dispensing solution starting from the point of entry into the hospital and other health care providers, through the central pharmacy, to the nursing station and to the patient's bedside. Omincell's medication-use product line includes its OmniRx, SinglePointe, AnywhereRN, Anesthesia Workstation, WorkflowRx, Controlled Substance Management, OmniLinkRx, Savvy Mobile Medication System, and Pandora Data Analytics products. In May 2012, the Company acquired MTS Medication Technologies, Inc. Headlines: (2/21) Omnicell, Inc. (OMCL): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report (2/24) Omnicell Introduces OptiFlex 12.0 for Improved Supply Inventory Management with Unique Device Identification (2/26) Omnicell Strengthens Global Presence with Opening of Beijing, China Office (2/24) Omnicell to Showcase Benefits of Interoperability and Clinical Analytics at HIMSS 2014 Conference (2/10) Omnicell Misses on Q4 Earnings, Beats Revs (2/25) Balanced View on Omnicell (2/25) Omnicell To Present At The Cowen And Company 34th Annual Health Care Conference (2/25) Balanced View on Omnicell - Analyst Blog Industry, Sector and Symbol: Sector: Healthcare Industry: Health Care Technology Sub-Industry: Health Care Technology Exchange: NASDAQ Symbol: OMCL CUSIP: 68213N10 Key Metrics: Previous Close: $28.9750 Day Moving Average: $27.2291200 Day Moving Average: $24.7968 P/E Ratio: 43.24P/E Growth: 1.32Market Cap: $1.030BCurrent Quarter EPS Consensus Estimate: $1.22 EPS Additional Links: View OMCL on Google FinanceView OMCL on Yahoo FinanceView OMCL's Company Profile on ReutersSearch for Omnicell Inc. on Google Omnicell (NASDAQ:OMCL) Chart for Tuesday, March, 11, 2014 (Chart Provided by Yahoo Finance) © Analyst Ratings Network 2010-2014. All rights reserved. Contact | Terms and Conditions | Subscribe | Subscribe Earnings | Google+ Analyst Ratings Network does not provide financial advice and does not issue recommendations or offers to buy or sell any security. Learn more.